Cargando…

Glycoproteome remodeling in MLL-rearranged B-cell precursor acute lymphoblastic leukemia

B-cell precursor acute lymphoblastic leukemia (BCP-ALL) with mixed-lineage leukemia gene rearrangement (MLL-r) is a poor-prognosis subtype for which additional therapeutic targets are urgently needed. Currently no multi-omics data set for primary MLL r patient cells exists that integrates transcript...

Descripción completa

Detalles Bibliográficos
Autores principales:	Oliveira, Tiago, Zhang, Mingfeng, Joo, Eun Ji, Abdel-Azim, Hisham, Chen, Chun-Wei, Yang, Lu, Chou, Chih-Hsing, Qin, Xi, Chen, Jianjun, Alagesan, Kathirvel, Almeida, Andreia, Jacob, Francis, Packer, Nicolle H, von Itzstein, Mark, Heisterkamp, Nora, Kolarich, Daniel
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Ivyspring International Publisher 2021
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8490503/ https://www.ncbi.nlm.nih.gov/pubmed/34646384 http://dx.doi.org/10.7150/thno.65398

Ejemplares similares

The Hitchhiker's guide to glycoproteomics
por: Oliveira, Tiago, et al.
Publicado: (2021)

Multi-Faceted Effects of ST6Gal1 Expression on Precursor B-Lineage Acute Lymphoblastic Leukemia
por: Zhang, Mingfeng, et al.
Publicado: (2022)

Improved strategy for large scale isolation of sialylglycopeptide (SGP) from egg yolk powder
por: Alagesan, Kathirvel, et al.
Publicado: (2019)

Rationale for targeting BCL6 in MLL-rearranged acute lymphoblastic leukemia
por: Hurtz, Christian, et al.
Publicado: (2019)

Decitabine demonstrates antileukemic activity in B cell precursor acute lymphoblastic leukemia with MLL rearrangements
por: Roolf, C., et al.
Publicado: (2018)

MLL rearrangements in pediatric acute lymphoblastic and myeloblastic leukemias: MLL specific and lineage specific signatures
por: Zangrando, Andrea, et al.
Publicado: (2009)

Identification of Genes Transcriptionally Responsive to the Loss of MLL Fusions in MLL-Rearranged Acute Lymphoblastic Leukemia
por: van der Linden, Marieke H., et al.
Publicado: (2015)

It is all about the solvent: on the importance of the mobile phase for ZIC-HILIC glycopeptide enrichment
por: Alagesan, Kathirvel, et al.
Publicado: (2016)

The landscape of somatic mutations in Infant MLL rearranged acute lymphoblastic leukemias
por: Andersson, Anna K, et al.
Publicado: (2015)

PROM1 and CTGF Expression in Childhood MLL-Rearrangement Acute Lymphoblastic Leukemia
por: Wang, Lu-lu, et al.
Publicado: (2022)

Treatment of B-cell precursor acute lymphoblastic leukemia with the Galectin-1 inhibitor PTX008
por: Paz, Helicia, et al.
Publicado: (2018)

Identification of co-expressed genes associated with MLL rearrangement in pediatric acute lymphoblastic leukemia
por: Zhang, Hao, et al.
Publicado: (2020)

Replication stress in MLL-rearrangements
por: Milyavsky, Michael, et al.
Publicado: (2015)

B-cell precursor acute lymphoblastic leukemia and stromal cells communicate through Galectin-3
por: Fei, Fei, et al.
Publicado: (2015)

Identification of hub genes and molecular mechanisms in infant acute lymphoblastic leukemia with MLL gene rearrangement
por: Zhang, Hao, et al.
Publicado: (2019)

Outcomes of acute lymphoblastic leukemia with KMT2A (MLL) rearrangement: the MD Anderson experience
por: Richard-Carpentier, Guillaume, et al.
Publicado: (2021)

Phosphoflow-Based Evaluation of Mek Inhibitors as Small-Molecule Therapeutics for B-Cell Precursor Acute Lymphoblastic Leukemia
por: George, Aswathi A., et al.
Publicado: (2015)

Galectin-1 and Galectin-3 in B-Cell Precursor Acute Lymphoblastic Leukemia
por: Fei, Fei, et al.
Publicado: (2022)

Erratum: Replication stress in MLL-rearrangements
por: Milyavsky, Michael, et al.
Publicado: (2016)

Systematic chemical and molecular profiling of MLL-rearranged infant acute lymphoblastic leukemia reveals efficacy of romidepsin
por: Cruickshank, M N, et al.
Publicado: (2017)

NG2 antigen is a therapeutic target for MLL-rearranged B-cell acute lymphoblastic leukemia
por: Lopez-Millan, Belen, et al.
Publicado: (2019)

Irinotecan Induces Disease Remission in Xenograft Mouse Models of Pediatric MLL-Rearranged Acute Lymphoblastic Leukemia
por: Kerstjens, Mark, et al.
Publicado: (2021)

Cytotoxicity of CD56-positive lymphocytes against autologous B-cell precursor acute lymphoblastic leukemia cells
por: Fei, Fei, et al.
Publicado: (2014)

UniCarbKB: building a knowledge platform for glycoproteomics
por: Campbell, Matthew P., et al.
Publicado: (2014)

Establishment of a novel human lymphoblastic cell strain with the long arm of chromosome 11 aberration without MLL rearrangement
por: Wang, Qian, et al.
Publicado: (2017)

EVI1 expression in childhood acute lymphoblastic leukaemia is not restricted to MLL and BCR/ABL rearrangements and is influenced by age
por: Stevens, A, et al.
Publicado: (2014)

Decitabine mildly attenuates MLL‐rearranged acute lymphoblastic leukemia in vivo, and represents a poor chemo‐sensitizer
por: Schneider, Pauline, et al.
Publicado: (2020)

RNA binding proteins in MLL-rearranged leukemia
por: Tran, Tiffany M., et al.
Publicado: (2022)

MLL Rearrangements Impact Outcome in HOXA-deregulated T-lineage Acute Lymphoblastic Leukemia: A Children's Oncology Group Study
por: Matlawska-Wasowska, Ksenia, et al.
Publicado: (2016)

Overcoming Microenvironment-Mediated Chemoprotection through Stromal Galectin-3 Inhibition in Acute Lymphoblastic Leukemia
por: Tarighat, Somayeh S., et al.
Publicado: (2021)

O-acetylated N-acetylneuraminic acid as a novel target for therapy in human pre-B acute lymphoblastic leukemia
por: Parameswaran, Reshmi, et al.
Publicado: (2013)

Congenital B-lymphoblastic leukemia with a cryptic MLL rearrangement and post-treatment evolution to mixed phenotype acute leukemia
por: Moschiano, Elizabeth, et al.
Publicado: (2016)

FOXM1 regulates leukemia stem cell quiescence and survival in MLL-rearranged AML
por: Sheng, Yue, et al.
Publicado: (2020)

Pharmacological inhibition of LSD1 for the treatment of MLL-rearranged leukemia
por: Feng, Zizhen, et al.
Publicado: (2016)

PAFc, a Key Player in MLL-rearranged Leukemogenesis
por: Tan, Jiaying, et al.
Publicado: (2010)

MLL-Rearranged Leukemias—An Update on Science and Clinical Approaches
por: Winters, Amanda C., et al.
Publicado: (2017)

Molecular pathogenesis of disease progression in MLL-rearranged AML
por: Kotani, Shinichi, et al.
Publicado: (2018)

ALOX5 exhibits anti-tumor and drug-sensitizing effects in MLL-rearranged leukemia
por: Wang, Yungui, et al.
Publicado: (2017)

MEK inhibition is a promising therapeutic strategy for MLL-rearranged infant acute lymphoblastic leukemia patients carrying RAS mutations
por: Kerstjens, Mark, et al.
Publicado: (2016)

Potent, p53-independent induction of NOXA sensitizes MLL-rearranged B-cell acute lymphoblastic leukemia cells to venetoclax
por: Fidyt, Klaudyna, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_i67vm92eobq1slqhlejubs5vmn